1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Global Autoimmune Disease Diagnostics Market

Global Autoimmune Disease Diagnostics Market

  • May 2013
  • -
  • Frost & Sullivan
  • -
  • 99 pages

Niche Opportunities in an Established In Vitro Diagnostics Market

This research service evaluates the global autoimmune disease diagnostics markets from 2009 to 2018. The market includes two segments, which include analysis for the markets for localized autoimmune disease diagnostic tests and for the systemic autoimmune disease diagnostic tests. This research service offers a discussion of the key market drivers and restraints, a detailed analysis of the changing competitive landscape of these markets, revenue forecasts for each segment and sub-segment, and the important trends that affect market growth. Lastly, this analysis presents and discusses three major market predictions and implications for market competitors.

Executive Summary

Total Autoimmune Disease Diagnostics Market Overview
• The total global autoimmune disease diagnostics market generated $Xmillion in 2012 and will reach $X million in 2018 with a compound annual growth rate (CAGR) of X percent from 2012 to 2018. Revenue growth is primarily driven in the United States (U.S.) market where the increasing incidence of gastrointestinal autoimmune conditions—primarily celiac disease—is promoting testing.
• A boost is expected for the U.S. autoimmune disease diagnostic testing market in 2014 due to the implementation of the Patient Protection and Affordable Care Act (PPACA). As PPACA expands healthcare coverage to an estimated X million people, there should be greater demand for autoimmune disease diagnostic testing.
• Product and technology innovation—advancing laboratory automation and personalized medicine—remains a critical market driver. However, no new blockbuster autoimmune disease diagnostic tests are expected to penetrate the market throughout the forecast period.
• Given the relatively low prevalence of autoimmune diseases, the autoimmune disease diagnostics market is forecasted to remain roughly X percent of the $X billion in vitro diagnostics market.

Localized Autoimmune Disease Segment
• In 2012, sales of localized autoimmune disease diagnostic tests amounted to an estimated $X million.
• Localized autoimmune diseases diagnostics test for organ or tissue specific conditions.
• Autoimmune diseases of the thyroid gland and gastrointestinal system accounted for Xand Xpercent of segment revenue in 2012.
• Constrained by the mature thyroid autoimmune disease diagnostics sub-segment, the size of the overall segment is anticipated to increase with aXpercent CAGR between 2012 and 2018.

Systemic Autoimmune Disease Segment
• In 2012, sales of systemic autoimmune disease tests generated an estimated $X million.
• The systemic autoimmune disease diagnostics market is maturing, with a CAGR of X percent expected during 2012 to 2018 period.
• Market growth is driven by primary care physicians’ continued adoption and growing utilization of specific tests when their patients present nonspecific symptoms.
• Rheumatoid arthritis (RA) testing drives approximately X percent of segment revenue.

Summary of Competitor Types

Total Autoimmune Disease Diagnostics Market: Competitor Types, Global, 2012

Multinational in vitro diagnostics vendors
• Recognized brand name
• Broad product portfolio
• Large sales force
• Significant cash reserves
Examples
• Abbott Diagnostics
• Beckman Coulter
• Roche Diagnostics
• Siemens
Competitive Factors
• High installed base of analyzers
• Complete test menu for thyroid disorders
• Availability of automated thyroid tests

Specialty autoimmune disease diagnostics vendors
• Strong branding around speciality
• Expert staff
• Esoteric product offering
Examples
• Aesku
• EuroImmune
• Inova Diagnostics
• SQI Diagnostics
Competitive Factors
• Broad test menu to address many autoimmune diseases
• Reliability of test results
• Effective distribution capabilities

Specialty autoimmune laboratories
• Novel testing capabilities
• Medical expertise
• Academic collaborations
Examples
• Crescendo Biosciences
• IMMCO Diagnostics
Competitive Factors
• Unique testing offering
• Immunopathologists with extensive clinical diagnostic and diagnostic pathology experience

CEO’s Perspective

1. Gastrointestinal autoimmune disease diagnostics will realize the most robust growth throughout the forecast period.
2. Increasing focus on autoimmune diseases in the U.S. makes the region an especially important target.
3. The most impactful innovations will enable greater automation and personalized medicine.
4. The competitor base will shrink as multinational in vitro diagnostics firms acquire niche market participants.
5. The competitor base will shrink as multinational in vitro diagnostics firms acquire niche market participants.

Key Questions This Study Will Answer

• How do growth rates in the autoimmune disease diagnostics market vary by segment and region?
• What are the most important growth drivers and opportunities in the market?
• What is the expected impact of emerging platforms for the automation of autoimmune disease diagnostic testing?
• Which autoimmune disease diagnostic laboratory tests are the most frequently ordered?
• What strategies should market competitors employ to gain share in mature segments of the autoimmune disease diagnostics market?
• What are the competitor profiles in this market and how do they compete for market share?

Table Of Contents

Global Autoimmune Disease Diagnostics Market
Table Of Contents

1. Executive Summary
2. Market Overview
3. Total Autoimmune Disease Diagnostics Market
• External Challenges: Drivers and Restraints
• Forecasts and Trends
4. Localized Autoimmune Disease Diagnostics Segment
• Forecasts and Trends
• Market Share and Competitive Analysis
5. Systemic Autoimmune Disease Diagnostics Segment
• Forecasts and Trends
• Market Share and Competitive Analysis
6. The Last Word (Conclusions and Implications)
7. Appendix

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025) Factors such as increased focus on human microbiome ...

Ankylosing spondylitis (AS)- Market Insights, Epidemiology and Market Forecast-2023

Ankylosing spondylitis (AS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Ankylosing spondylitis (AS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.